179 related articles for article (PubMed ID: 7294537)
1. Learning from quantitation.
Alons CL; Veldhuizen RW; Boon ME
Anal Quant Cytol; 1981 Sep; 3(3):178-81. PubMed ID: 7294537
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between primary pleural and primary peritoneal mesotheliomas by morphometry and analysis of the vacuolization pattern of the exfoliated mesothelial cells.
Boon ME; Kwee HS; Alons CL; Morawetz F; Veldhuizen RW
Acta Cytol; 1982; 26(2):103-8. PubMed ID: 6952709
[TBL] [Abstract][Full Text] [Related]
3. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M
Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
[TBL] [Abstract][Full Text] [Related]
4. The cytopathology of mesothelioma.
Tao LC
Acta Cytol; 1979; 23(3):209-13. PubMed ID: 294056
[TBL] [Abstract][Full Text] [Related]
5. Exfoliative cytology of diffuse mesothelioma.
Roberts GH; Campbell GM
J Clin Pathol; 1972 Jul; 25(7):577-82. PubMed ID: 5070255
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid.
Kwee WS; Veldhuizen RW; Alons CA; Morawetz F; Boon ME
Acta Cytol; 1982; 26(4):401-6. PubMed ID: 6957089
[TBL] [Abstract][Full Text] [Related]
7. The cytology of malignant mesothelioma in Western Australia.
Whitaker D; Shilkin KB
Acta Cytol; 1978; 22(2):67-70. PubMed ID: 276234
[TBL] [Abstract][Full Text] [Related]
8. Role of computerized morphometric analysis in diagnosis of effusion specimens.
Arora B; Setia S; Rekhi B
Diagn Cytopathol; 2006 Oct; 34(10):670-5. PubMed ID: 16955473
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
10. Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.
van de Molengraft FJ; van 't Hof MA; Herman CJ; Vooijs PG
Anal Quant Cytol; 1982 Sep; 4(3):217-20. PubMed ID: 7149486
[TBL] [Abstract][Full Text] [Related]
11. The cytologic diagnosis of mesothelioma.
Ehya H
Semin Diagn Pathol; 1986 Aug; 3(3):196-203. PubMed ID: 3616223
[TBL] [Abstract][Full Text] [Related]
12. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
13. [Comparing electron microscopical investigation of cells from mesotheliomas (author's transl)].
Jaugitz H
Arch Geschwulstforsch; 1977; 47(3):204-9. PubMed ID: 907441
[TBL] [Abstract][Full Text] [Related]
14. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
Pisharodi LR; Bedrossian CW
Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
[TBL] [Abstract][Full Text] [Related]
15. [Mesothelioma of the pleura: cytology, coagulation of protein (Weltmann) and hyaluronic acid as parameters of clinical diagnosis (author's transl)].
Matzel W
Z Erkr Atmungsorgane; 1980; 155(1):133-9. PubMed ID: 7210738
[TBL] [Abstract][Full Text] [Related]
16. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
17. Digital image analysis in cytological diagnosis: a morphometric analysis on pleural mesotheliomas.
Christen H; Oberholzer M; Buser M; Lötscher R; Gschwind R; Rösel F; Ettlin R; Feess A; Dalquen P
Anal Cell Pathol; 1989 Apr; 1(2):105-22. PubMed ID: 2487514
[TBL] [Abstract][Full Text] [Related]
18. Cell aggregates in malignant mesothelioma.
Whitaker D
Acta Cytol; 1977; 21(2):236-9. PubMed ID: 266334
[TBL] [Abstract][Full Text] [Related]
19. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
20. Benign and malignant mesothelial proliferations.
Koss LG
Am J Surg Pathol; 2001 Apr; 25(4):548-9. PubMed ID: 11257637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
